BioMarin Announces Favorable Results from Global Phase 2 Study of VOXZOGO™ (vosoritide) for Injection in Infants and Young Children with Achondroplasia at The Endocrine Society Annual Meeting, END...
Improvement in Height Z-Score and Annualized Growth Velocity Observed, Consistent with Children Over 5Interactions with Health Authorities Planned...
Source: businessinsider.com